本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Ligand Pharmaceuticals Inc.

284.47
-4.7800-1.65%
盤後284.470.00000.00%19:57 EDT
成交量:26.12萬
成交額:7,458.64萬
市值:56.71億
市盈率:29.30
高:294.00
開:291.48
低:283.77
收:289.25
52周最高:326.63
52周最低:161.82
股本:1,993.56萬
流通股本:1,935.39萬
量比:1.31
換手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):9.71
每股收益(LYR):6.13
淨資產收益率:21.96%
總資產收益率:3.99%
市淨率:5.86
市盈率(LYR):46.41

資料載入中...

2024/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/19

重要事件披露

Form 8-K - Current report
2024/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/01

重要事件披露

Form 8-K - Current report
2023/11/10

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]